SHARE-BASED COMPENSATION - Narrative (Details)		1 Months Ended				6 Months Ended	7 Months Ended	8 Months Ended	12 Months Ended
	Jun. 03, 2021	Aug. 31, 2021 $ / shares shares	Jun. 30, 2021 $ / shares shares	Mar. 31, 2021 $ / shares shares	Mar. 31, 2020 USD ($) award $ / shares shares	Jun. 30, 2021 $ / shares	Dec. 31, 2019 USD ($) $ / shares	Sep. 03, 2019 USD ($)	Dec. 31, 2021 USD ($) $ / shares shares	Dec. 31, 2020 USD ($) $ / shares shares	Dec. 31, 2019 $ / shares	Feb. 15, 2021 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options outstanding, weighted average exercise price (in usd per share) | $ / shares							$ 0		$ 7.68	$ 7.94	$ 0
Award vesting rights, percentage									20.00%
Granted (in shares) | shares		8,152	198,929
Income tax (expense) benefit | $							$ (858,000)	$ (23,288,000)	$ (619,000)	$ (1,904,000)
Share-based compensation arrangement by share-based payment award, cash received upon exercise | $									1,400,000	0
Options, nonvested, weighted average grant date fair value, reduction (in usd per share) | $ / shares												$ 1.18
Options nonvested, number of shares | shares												3,653,837
Option, nonvested, weighted average exercise price (in usd per share) | $ / shares												$ 7.94
Options, outstanding, intrinsic value | $									2,200,000
Options, exercisable, intrinsic value | $									$ 2,200,000	2,200,000
Granted (in usd per share) | $ / shares									$ 13.35		$ 7.94
Number of long term incentive awards | award					56
2021 Omnibus Incentive Compensation Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment award expiration period	10 years
Share-based Payment Arrangement, Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rights, percentage			25.00%	25.00%
Award vesting period									4 years
Income tax (expense) benefit | $							$ 0		$ 2,100,000
Effective income tax rate reconciliation, tax expense, share-based payment arrangement, amount | $									$ 1,900,000	$ 80,000.00
Granted (in usd per share) | $ / shares									$ 4.60
Share-based payment arrangement, nonvested award, option, cost not yet recognized, amount | $									$ 10,400,000
Share-based payment arrangement, nonvested award, cost not yet recognized, period for recognition									2 years 4 months 17 days
Share-based Payment Arrangement, Option | 2021 Omnibus Incentive Compensation Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment award expiration period		5 years
Share-based payment award, shares issued in period | shares		20,380	497,321
Options outstanding, weighted average exercise price (in usd per share) | $ / shares		$ 9.20	$ 14.00			$ 14.00
Share-based Payment Arrangement, Option | 2019 Equity Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment award expiration period			10 years	10 years	10 years
Share-based payment award, shares issued in period | shares				69,300	5,723,676
Options outstanding, weighted average exercise price (in usd per share) | $ / shares				$ 9.92	$ 7.94
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period						3 years
Granted (in shares) | shares									207,081
Outstanding at beginning of period (in shares) | $ / shares		$ 9.20	$ 13.00			$ 13.00
Share-based payment arrangement, nonvested award, excluding option, cost not yet recognized, amount | $									$ 1,800,000
Share-based payment arrangement, nonvested award, cost not yet recognized, period for recognition									3 years 5 months 15 days
Exercised (in shares) | shares									8,152
LTI Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares) | shares									0	56
Equity instruments other than options, aggregate intrinsic value, nonvested | $					$ 1,100,000
Exercised (in shares) | shares									0
Share-based compensation arrangement by share-based payment award, equity instruments other than options, cancelled in period | shares									0